• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉西他滨联合顺铂治疗初始不可切除的伴腹膜转移的胆囊癌后的转化手术:病例报告

Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.

作者信息

Wakasa Yusuke, Toyoki Yoshikazu, Kusumi Tomomi, Kameyama Yuma, Odagiri Tadashi, Jin Hiroyuki, Nakai Makoto, Aoki Kazunori, Kawashima Hiroaki, Endo Masaaki

机构信息

Department of General Surgery, Aomori City Hospital, 1-14-20, Katta, Aomori, 030-0821, Japan.

Department of Pathology, Aomori City Hospital, Aomori, Japan.

出版信息

Surg Case Rep. 2022 Mar 25;8(1):50. doi: 10.1186/s40792-022-01406-9.

DOI:10.1186/s40792-022-01406-9
PMID:35332404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948309/
Abstract

BACKGROUND

Conversion surgery, which is defined as chemotherapy or chemoradiotherapy followed by radical surgery, may improve survival of patients with initially unresectable advanced biliary tract cancer, including gallbladder cancer. However, there are few reports on conversion surgery for advanced gallbladder cancer.

CASE PRESENTATION

A 69-year-old woman was referred to our hospital with initially unresectable gallbladder cancer with peritoneal carcinomatosis. She underwent gemcitabine plus cisplatin therapy for 9 months. Extended cholecystectomy, resection of the extrahepatic bile duct with regional lymph node dissection, and total omentectomy were then performed as conversion surgery. The patient has survived without recurrence for 19 months postoperatively (31 months after the initial diagnosis) while continuing chemotherapy.

CONCLUSIONS

This case suggests that conversion surgery for advanced gallbladder cancer is effective and may be curative for locally advanced disease and distant metastasis such as peritoneal carcinomatosis.

摘要

背景

转化手术定义为化疗或放化疗后行根治性手术,其可能改善包括胆囊癌在内的初始不可切除的晚期胆管癌患者的生存率。然而,关于晚期胆囊癌转化手术的报道较少。

病例介绍

一名69岁女性因初始不可切除的伴有腹膜癌转移的胆囊癌转诊至我院。她接受了9个月的吉西他滨联合顺铂治疗。随后行扩大胆囊切除术、肝外胆管切除及区域淋巴结清扫术和全网膜切除术作为转化手术。患者术后存活19个月无复发(初始诊断后31个月),同时继续化疗。

结论

该病例提示晚期胆囊癌转化手术是有效的,对于局部晚期疾病及远处转移如腹膜癌转移可能具有治愈性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/c0f3d4f9a5a7/40792_2022_1406_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/62d9085a3825/40792_2022_1406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/0af2161128b9/40792_2022_1406_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/6fe09867cbda/40792_2022_1406_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/c0f3d4f9a5a7/40792_2022_1406_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/62d9085a3825/40792_2022_1406_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/0af2161128b9/40792_2022_1406_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/6fe09867cbda/40792_2022_1406_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3385/8948309/c0f3d4f9a5a7/40792_2022_1406_Fig4_HTML.jpg

相似文献

1
Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.吉西他滨联合顺铂治疗初始不可切除的伴腹膜转移的胆囊癌后的转化手术:病例报告
Surg Case Rep. 2022 Mar 25;8(1):50. doi: 10.1186/s40792-022-01406-9.
2
Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report.吉西他滨联合顺铂治疗初始不可切除的晚期胆囊癌实现病理完全缓解:一例报告
Surg Case Rep. 2022 Jan 26;8(1):20. doi: 10.1186/s40792-022-01375-z.
3
Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review.吉西他滨联合顺铂化疗治疗初始不可切除的晚期胆管癌的转化手术:1例病例报告及文献综述
Int Cancer Conf J. 2022 Mar 29;11(3):188-195. doi: 10.1007/s13691-022-00545-y. eCollection 2022 Jul.
4
[A Case of Gallbladder Cancer with Para-Aortic Lymph Node Metastasis Successfully Treated by Gemcitabine plus Cisplatin Combination Chemotherapy and Conversion Surgery].[1例经吉西他滨联合顺铂化疗及转化手术成功治疗的伴有主动脉旁淋巴结转移的胆囊癌]
Gan To Kagaku Ryoho. 2020 Dec;47(13):2204-2206.
5
[A Case of Conversion Surgery Following Chemotherapy in Initially Unresectable Locally Advanced Gallbladder Carcinoma].[1例初始不可切除的局部进展期胆囊癌化疗后行转化手术的病例]
Gan To Kagaku Ryoho. 2019 Apr;46(4):775-777.
6
Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report.局部晚期胆囊癌经有效化疗和随后的根治性切除治疗:1 例报告。
J Med Case Rep. 2022 Jan 17;16(1):30. doi: 10.1186/s13256-021-03248-9.
7
Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature.新辅助化疗后对初始不可切除的转移性胆囊癌进行根治性手术切除:病例报告及文献复习
Int J Surg Case Rep. 2022 Nov;100:107694. doi: 10.1016/j.ijscr.2022.107694. Epub 2022 Sep 21.
8
[A Case of Successful Curative Resection Following Downsizing Chemotherapy in Initially Unresectable Locally Advanced Gallbladder Carcinoma].[一例初始不可切除的局部进展期胆囊癌经减瘤化疗后成功根治性切除的病例]
Gan To Kagaku Ryoho. 2015 Nov;42(12):1726-8.
9
Case report: From palliative to potentially curative - the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma.病例报告:从姑息治疗到潜在治愈——免疫疗法的出现为晚期胆囊腺癌带来希望。
Front Immunol. 2024 Feb 2;15:1353430. doi: 10.3389/fimmu.2024.1353430. eCollection 2024.
10
[Three Cases of Conversion Surgery for Unresectable Advanced Gallbladder Cancer with Distant Metastasis Treated with Gemcitabine plus CDDP].[吉西他滨联合顺铂治疗不可切除的晚期胆囊癌伴远处转移的三例转化手术病例]
Gan To Kagaku Ryoho. 2023 Dec;50(13):1792-1794.

引用本文的文献

1
A case of successful conversion surgery for unresectable gallbladder cancer treated with durvalumab in combination with gemcitabine plus cisplatin.一例采用度伐利尤单抗联合吉西他滨加顺铂治疗的不可切除胆囊癌成功转化手术病例。
Clin J Gastroenterol. 2025 Feb;18(1):161-168. doi: 10.1007/s12328-024-02053-3. Epub 2024 Oct 22.
2
Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study.PD-1/PD-L1 抑制剂联合治疗初治不可切除胆道癌后有缓解的患者中,转为手术干预与继续系统治疗的效果比较:一项回顾性队列研究。
Int J Surg. 2024 Aug 1;110(8):4608-4616. doi: 10.1097/JS9.0000000000001540.
3

本文引用的文献

1
Conversion surgery for initially unresectable extrahepatic biliary tract cancer.针对初始不可切除的肝外胆管癌的转化手术
Ann Hepatobiliary Pancreat Surg. 2021 Aug 31;25(3):349-357. doi: 10.14701/ahbps.2021.25.3.349.
2
The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.腹腔灌洗细胞学检查对胆道癌的影响(KHBO1701):关西肝胆肿瘤研究组。
Cancer Rep (Hoboken). 2021 Apr;4(2):e1323. doi: 10.1002/cnr2.1323. Epub 2020 Dec 6.
3
Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: A retrospective study based on SEER data.
PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.PD-L1 抑制剂联合吉西他滨和顺铂治疗后行转化手术治疗初治不可切除的晚期胆囊癌。
BMJ Case Rep. 2023 Dec 20;16(12):e255403. doi: 10.1136/bcr-2023-255403.
4
Induction chemotherapy and hepatic artery embolization followed by extended resection for locally advanced gallbladder cancer: a case report.诱导化疗和肝动脉栓塞术联合扩大切除术治疗局部晚期胆囊癌:一例报告
Surg Case Rep. 2023 May 15;9(1):79. doi: 10.1186/s40792-023-01664-1.
5
Progress in gallbladder cancer with lymph node metastasis.伴有淋巴结转移的胆囊癌的进展
Front Oncol. 2022 Aug 22;12:966835. doi: 10.3389/fonc.2022.966835. eCollection 2022.
2010年至2015年原发性胆囊癌患者的生存分析:一项基于监测、流行病学和最终结果(SEER)数据的回顾性研究。
Medicine (Baltimore). 2020 Oct 2;99(40):e22292. doi: 10.1097/MD.0000000000022292.
4
Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study.初始不可切除的胆道恶性肿瘤的转化手术:一项多中心回顾性队列研究。
Surg Today. 2020 Nov;50(11):1409-1417. doi: 10.1007/s00595-020-02031-5. Epub 2020 May 28.
5
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.吉西他滨联合 S-1 对比吉西他滨联合顺铂治疗晚期/复发性胆道癌:FUGA-BT(JCOG1113)随机 III 期临床试验。
Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402.
6
Essential updates to the surgical treatment of biliary tract cancer.胆道癌手术治疗的重要更新。
Ann Gastroenterol Surg. 2019 May 22;3(4):378-389. doi: 10.1002/ags3.12266. eCollection 2019 Jul.
7
Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis.长链非编码RNA作为胆囊癌潜在的生物标志物和治疗靶点:一项系统综述和荟萃分析
Cancer Cell Int. 2019 Jun 28;19:169. doi: 10.1186/s12935-019-0891-1. eCollection 2019.
8
Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification.IV期胃癌是否可行转化治疗:新的生物学分类范畴建议
Gastric Cancer. 2016 Apr;19(2):329-338. doi: 10.1007/s10120-015-0575-z. Epub 2015 Dec 7.
9
Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.对于接受吉西他滨联合顺铂化疗后再行根治性手术的初始不可切除的局部晚期胆管癌患者,缩减化疗方案。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1093-9. doi: 10.1245/s10434-015-4768-9. Epub 2015 Aug 4.
10
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.辅助手术对初始不可切除的胰腺癌患者的作用:这些患者对非手术抗癌治疗有长期良好反应,日本肝胆胰外科学会胰腺手术项目研究结果
J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):590-600. doi: 10.1007/s00534-013-0616-0.